Among a flurry of executive actions, Mr. Trump directed the nation’s nuclear safety regulator to speed up approvals for new ...

The administration is seeking to lower costs by obtaining “most favored nation” status among pharmaceutical companies.

President Donald Trump has signed a sweeping executive order setting a 30-day deadline for drugmakers to lower the cost of ...